Modification of certain vascular responses to dopamine by morphine.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D003864:Depression, Chemical; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D006439:Hemodynamics / Q000187:drug effects*; D007668:Kidney / Q000098:blood supply; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D009269:Nalorphine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011955:Receptors, Drug / Q000187:drug effects; D012039:Regional Blood Flow / Q000187:drug effects; D012077:Renal Artery / Q000502:physiology; D013116:Spinal Cord / Q000502:physiology; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology
D011955:Receptors, Drug; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D009020:Morphine; D006220:Haloperidol; D009269:Nalorphine; D004298:Dopamine; D004837:Epinephrine